Try our Advanced Search for more refined results

Expert Analysis

France's Biosimilar Law May Set Trend Inside The EU

Law360, New York ( February 18, 2014, 6:26 PM EST) -- Beginning on Jan. 1, 2014, French pharmacists are now legally permitted to substitute a biosimilar for the prescribed (reference) biological medicine, as long as the prescribing physician has not marked the prescription as "nonsubstitutable. " While the details will be defined via the enactment of implementing decrees, under the 2014 Social Security Financing Law ("SSFL"), substitution will be allowed only when initiating a course of treatment, and if the biosimilar belongs to the same group as the prescribed product, known as a "similar biologic group. ". . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!